AOsteoporosis
First line
Osteoporosis
First line
Prevention and treatment of osteoporosis combined with disease-modifying therapy (bisphosphonates, denosumab, romosozumab). Per NOF 2022 and SEIOMM 2022, without adequate calcium and vitamin D any osteoporosis therapy loses efficacy. Dose: 1000–1500 mg elemental calcium + 800–1000 IU vitamin D3 per day, in two divided doses with meals. Do not co-administer calcium with bisphosphonates – separate by at least 2 hours. Baseline 25(OH)D – correct deficiency with cholecalciferol monotherapy first.
Sources
- AEMPS: Ficha técnica de Calcio + Colecalciferol (2024)
- Cochrane Database Syst Rev: Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. (2014)
- Osteoporos Int: Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. (2016)
- JAMA: Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. (2017)
ICD-10: M81 · ICD-11: FB83.1